Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Turn Innovation On!
Key Thematics

Start4Health is dedicated to driving innovation in the healthcare industry. To achieve this, we focus on five key thematic pillars that encompass a wide range of solutions. These pillars serve as the foundation for the transformative ideas and technologies we aim to support.

We encourage the submission of solutions that tackle key public health challenges and other unmet needs. Are you ready to make your mark? 

Image
Telemedicine icon
Digital Health and Medicine
Leveraging AI, IoT, digital biomarkers, and personalized medicine to transform diagnosis, treatment, and care, including AI-powered medical knowledge and decision support.
Image
Wearables icon
Computational Biology & Biomedical Data Science Solutions 
Applying computational biology, AI, and advanced data science to biological, clinical, and real-world data to generate evidence and insights, accelerate scientific discovery, and advance precision medicine. 
Image
Monitoring icon
Clinical Trial Technologies 
Innovative technologies that make clinical trials more efficient, accessible, and patient-centric, optimizing trial operations while improving study execution, data quality, patient recruitment, engagement, and health outcomes.
Image
Drug Safety
Drug Safety 
Novel solutions that enhance detection, monitoring, reporting, and analysis of safety data, enabling faster insights, more effective regulatory response, and improved patient safety. 
Image
Support icon
Patient & HCP Engagement 
Innovative solutions that empower patients and healthcare professionals through better information, communication, education, and support, promoting treatment adherence and better health outcomes. 
Acceleration Lab

Pfizer’s Center for Digital Innovation invites startups from Greece, Israel, and Cyprus to help shape the future of healthcare through digital innovation as Start4Health enters its 5th year. 

Open Call Phase

Pfizer’s Center for Digital Innovation invites startups from Greece, Israel, and Cyprus to help shape the future of healthcare through digital innovation with their pioneering ideas and solutions as Start4Health enters its 5th year. The Open Call phase will begin on November 18, 2026 and will run until January 9, 2027 (11:59 p.m. EET).

Accelerator

The Top 5 startups will enter the Acceleration Phase for eight weeks and will be assisted by Pfizer Mentors and Coaches from the ecosystem.

Final Pitch Day

The Final Pitch Day includes pitches, events, and awards for the Top 2 startups.

Phase 1
Call for applications
18/11/2026 - 09/01/2027
Phase 2
Assessment
January 2027
Phase 3
Kick-off Bootcamp
February 2027
Phase 4
Accelerator
February 2027 - April 2027
Phase 5
Final Pitch-day
April 2027
ScaleUps Studio

ScaleUps Studio is exclusively designed to unlock strategic collaboration opportunities for mature startups and healthtech providers from Greece, Israel, and Cyprus. As a gateway to Pfizer’s Center for Digital Innovation and the broader Pfizer organization, the program enables established companies to present their value proposition and explore concrete pathways for potential partnerships and collaboration.

The Open Call phase will begin on November 18, 2026 and will run until January 9, 2027 (11:59 p.m. EET).

Selected startups take part in ScaleUps Studio from February to March 2027.

The Selection Process

Our dedicated Review Committee, comprising Pfizer experts and industry professionals, will evaluate your entry based on a range of criteria, including among others your company's maturity, the relevance to Pfizer’s business, the product/service scalability and the innovation potential.

By participating, you acknowledge and embrace the Review Committee's final decisions, knowing that each evaluation is tailored to the unique needs and business priorities of the company.

During the ScaleUps Studio

Once selected, you'll gain exclusive access to the ScaleUps Studio—a tailored program of meetings and workshops with global Pfizer executives, co-designed around the specific collaboration opportunities your solution offers.
Each team begins with a 1:1 Preparation Workshop to refine their proposal and identify synergies.
Next, they join an Intro Meeting with the Pfizer CDI team to present their solution and explore alignment within Pfizer’s global network.
The process culminates in a Solution Exploration Session, where teams engage with Pfizer stakeholders in focused discussions to assess fit, uncover synergies, and define next steps

What's in it for You

While there is no monetary prize associated with participating in the ScaleUps Studio, the benefits are great By engaging directly with Pfizer’s CDI, ScaleUps Studio gives you the opportunity to explore potential partnerships, co-development prospects, and strategic alliances that can propel your company to new heights.

It's important to note that entering the ScaleUps Studio doesn't automatically lead to legally binding contractual agreements with Pfizer. However, ScaleUps Studio is a dedicated gateway to present your solution and investigate separate, tailored agreements in the future. 

Don't miss this chance to revolutionize your business and make a lasting impact in the pharmaceutical and healthcare industry.Apply now to the ScaleUps Studio and embark on a transformative journey with Pfizer. 

 

Prizes and Benefits

The program is designed to attract ambitious startups and founders ready to scale impactful solutions in health innovation.

A judging committee, made up of global and local experts from Pfizer and the broader innovation ecosystem, will evaluate and select the Top 5 startups to join the Acceleration Phase.

During this phase, each team will work closely with a dedicated mentor from Pfizer’s global network, and engage in tailored coaching and expert-led sessions to refine their product, strengthen their business model, sharpen their value proposition and enhance their pitching skills.

On the Final Pitch Day, the judging committee will select two winning teams with the most compelling pitches, who will receive significant cash prizes. Beyond the awards, any participating startups with strong and compelling business cases will have the opportunity to explore a potential collaboration with Pfizer CDI.

1st Winner

25.000€ 
Potential collaboration opportunities with Pfizer 

2nd Winner

10.000€ 
Potential collaboration opportunities with Pfizer 

Judges
Pandis, Yannis
Pandis, Yannis
Thessaloniki Site Lead and Center for Digital Innovation Lead, Pfizer
Matonaki, Anastasia
Matonaki, Anastasia
Director, Embedded Innovation, Pfizer
Dolev Golan, Gali
Dolev Golan, Gali
AI Strategy Lead Portfolio & Innovation Pfizer R&D
Kimalov, Boaz
Kimalov, Boaz
Country Medical Lead – Israel, Pfizer
Zakopoulos, Filippos
Zakopoulos, Filippos
Managing Partner, Found.ation
Mentors
Jafari, Idin A
Jafari, Idin A
Director, Digital Strategy & Innovation Intelligence, Pfizer
Henri, Kuqali
Kuqali, Henri
Solutions Delivery Lead, Pfizer
Loulos, Vasilis
Loulos, Vasilis
Director, AI & Solutions Engineering, Pfizer
Cohen, Yaniv
Cohen, Yaniv
Digital & Technology Lead, East Europe, Pfizer
Bompoli, Elisavet
Bompoli, Elisavet
Global Clinical Supply (GCS) AI & Business Insights Lead and GCS Greece Strategic Hub Lead, Pfizer
Hear from Previous Winners

Discover the inspiring success stories of previous winners who have embarked on the transformative journey of Start4Health. These companies have experienced firsthand the many opportunities and invaluable support offered through this groundbreaking initiative. Let their stories inspire you to take the leap and unlock your own potential for growth and innovation.

Image
ABCureD
ABCureD
“Beyond an award, Start4Health was a vote of confidence in ABCureD’s vision to transform diabetes care through precision diagnostics. The insightful discussions with industry mentors helped us broaden our value proposition, revealing the potential of our technology as a metabolic pharmacodynamic biomarker and a valuable tool for drug R&D. A powerful reminder that connecting scientific innovation with pharmaceutical industry expertise can open new pathways to impact.”

ABCureD Team
Image
Altroviai
Altrovia
“Being part of Start4Health has been a fantastic experience for us at Altrovia. The program gave us the opportunity to learn directly from Pfizer’s teams, challenge our thinking, and make valuable connections along the way. What really stood out was the genuine enthusiasm, support, and personal attention from the Pfizer team, who went above and beyond to help us throughout the journey. We’re truly grateful to everyone involved for making this such a rewarding experience and for their commitment to supporting healthcare innovation in Greece and beyond.”

Altrovia Team
Image
Polymodels-Hub
Polymodels Hub
"Start4Health has been a very positive experience for us at PolyModels Hub. The programme was well organised, and we received guidance and support throughout. We appreciated the care that went into the programme and the opportunity to build a working relationship with the pharma organisation. We are currently working with Pfizer on a project which will use our ModelFlow platform. ModelFlow brings together data and modelling to help pharmaceutical teams understand their processes and make informed decisions. We are pleased to have reached this stage and look forward to the next steps of our wider collaboration. It has been a pleasure to take part in the programme, and we want to thank the Start4Health team for their guidance and support.”

Polymodels Hub Team
Image
Scidrones
Scidrones
"Start4Health was a truly transformative experience for Scidrones. The program gave us the opportunity to work closely with leading mentors, gain exposure to Pfizer’s ecosystem, and refine our solution with a sharper focus on real-world healthcare impact. Beyond the financial support, it was the strategic insights, peer learning, and collaborative spirit that made the difference. Winning the 2024 Acceleration Lab not only validated the hard work of our team but also gave us the momentum and visibility to scale our innovation further."

Scidrones Team
Image
Aima-Labs
Aima Labs
"AimaLabs is revolutionizing hematology diagnostics with an innovative AI-powered software platform for peripheral blood smear analysis. Our vision is to enhance patient care by making advanced, AI-driven diagnostics accessible to laboratories and hospitals worldwide, helping to address the critical gap where millions of cases of anemia and blood cancer go undiagnosed.
Being selected for Pfizer's Start4Health accelerator was a truly transformative experience in pursuit of this goal. It was during this program that we developed the roadmap to take AimaLabs from a research-driven concept and put it on the path to becoming a real-world product.
The real game-changer was our mentor, Klaudia Eriksson. Her guidance helped us navigate the complex journey from lab to market strategy. To cap off an incredible experience, we were thrilled to be recognized by Pfizer's team, who awarded us the 2nd prize in the competition. This recognition was a powerful validation of our vision and hard work. The insights from the Start4Health program and Klaudia's mentorship are now foundational to our strategy, positioning us to accelerate development and bring our mission to life".

Aima Labs Team

Stay up to date

Stay tuned for the latest updates. Subscribe to our newsletter

I would like to receive information and updates regarding the Pfizer Center for Digital Innovation in Thessaloniki and other Pfizer initiatives in accordance with Pfizer's Privacy Policy.